摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

(R)-3-(1-(2-chlorophenyl)ethoxy)-5-(5-(2-(1-methylpiperidin-4-ylamino)pyrimidin-4-yl)-1H-benzo[d]imidazol-1-yl)thiophene-2-carboxamide | 1245927-51-8

中文名称
——
中文别名
——
英文名称
(R)-3-(1-(2-chlorophenyl)ethoxy)-5-(5-(2-(1-methylpiperidin-4-ylamino)pyrimidin-4-yl)-1H-benzo[d]imidazol-1-yl)thiophene-2-carboxamide
英文别名
3-[(1R)-1-(2-chlorophenyl)ethoxy]-5-[5-[2-[(1-methylpiperidin-4-yl)amino]pyrimidin-4-yl]benzimidazol-1-yl]thiophene-2-carboxamide
(R)-3-(1-(2-chlorophenyl)ethoxy)-5-(5-(2-(1-methylpiperidin-4-ylamino)pyrimidin-4-yl)-1H-benzo[d]imidazol-1-yl)thiophene-2-carboxamide化学式
CAS
1245927-51-8
化学式
C30H30ClN7O2S
mdl
——
分子量
588.133
InChiKey
TYQDNFSUWCTPOC-GOSISDBHSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    5.7
  • 重原子数:
    41
  • 可旋转键数:
    8
  • 环数:
    6.0
  • sp3杂化的碳原子比例:
    0.27
  • 拓扑面积:
    139
  • 氢给体数:
    2
  • 氢受体数:
    8

反应信息

  • 作为产物:
    描述:
    4-氨基-1-甲基哌啶 、 5-[5-(2-chloropyrimidin-4-yl)-1H-benzimidazol-1-yl]-3-({(1R)-1-[2-chlorophenyl]ethyl}oxy)thiophene-2-carboxamide 生成 (R)-3-(1-(2-chlorophenyl)ethoxy)-5-(5-(2-(1-methylpiperidin-4-ylamino)pyrimidin-4-yl)-1H-benzo[d]imidazol-1-yl)thiophene-2-carboxamide
    参考文献:
    名称:
    Heteroaryl-linked 5-(1H-benzimidazol-1-yl)-2-thiophenecarboxamides: Potent inhibitors of polo-like kinase 1 (PLK1) with improved drug-like properties
    摘要:
    Potent inhibitors of PLK1 with acceptable solubility, mouse iv clearance, and reduced CYP450 inhibition were identified. Drug-like properties were improved using a heteroaryl ring as a functional handle for manipulation of inhibitors' physiochemical and DMPK properties. (C) 2010 Elsevier Ltd. All rights reserved.
    DOI:
    10.1016/j.bmcl.2010.06.009
点击查看最新优质反应信息

文献信息

  • Heteroaryl-linked 5-(1H-benzimidazol-1-yl)-2-thiophenecarboxamides: Potent inhibitors of polo-like kinase 1 (PLK1) with improved drug-like properties
    作者:Tara R. Rheault、Kelly H. Donaldson、Jennifer G. Badiang-Alberti、Ronda G. Davis-Ward、C. Webb Andrews、Ramesh Bambal、Jeffrey R. Jackson、Mui Cheung
    DOI:10.1016/j.bmcl.2010.06.009
    日期:2010.8
    Potent inhibitors of PLK1 with acceptable solubility, mouse iv clearance, and reduced CYP450 inhibition were identified. Drug-like properties were improved using a heteroaryl ring as a functional handle for manipulation of inhibitors' physiochemical and DMPK properties. (C) 2010 Elsevier Ltd. All rights reserved.
查看更多